We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ABT market cap is 182.08B. The company's latest EPS is USD 3.9935 and P/E is 26.26.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 11.26B | 10.41B | 10.09B | 9.75B | 9.98B |
| Operating Income | 2.38B | 1.77B | 1.3B | 1.51B | 1.54B |
| Net Income | 2.02B | 1.44B | 1.03B | 1.32B | 1.38B |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 30.58B | 31.9B | 34.61B | 43.08B | 43.65B |
| Operating Income | 3.65B | 4.53B | 5.36B | 8.43B | 8.36B |
| Net Income | 2.37B | 3.69B | 4.5B | 7.07B | 6.93B |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 74.2B | 72.8B | 74.44B | 73.79B | 73.35B |
| Total Liabilities | 37.49B | 36.92B | 37.53B | 36.56B | 35.95B |
| Total Equity | 36.72B | 35.88B | 36.91B | 37.23B | 37.4B |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 67.17B | 67.89B | 72.55B | 75.2B | 74.44B |
| Total Liabilities | 36.45B | 36.59B | 39.55B | 39.17B | 37.53B |
| Total Equity | 30.72B | 31.3B | 33B | 36.02B | 36.91B |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 4.48B | 7.26B | 9.58B | 1.14B | 2.35B |
| Investing | -624M | -1.11B | -1.74B | -462M | -1.68B |
| Financing | -4.64B | -6.18B | -7.64B | -1.41B | -2.7B |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 6.3B | 6.14B | 7.9B | 10.53B | 9.58B |
| Investing | -1.36B | -1.82B | -2.22B | -2.01B | -1.74B |
| Financing | -10.39B | -4.29B | -2.78B | -5.49B | -7.64B |
| Market Cap | 182.08B |
| Price to Earnings Ratio | 26.26 |
| Price to Sales Ratio | 4.17 |
| Price to Cash Ratio | 18.43 |
| Price to Book Ratio | 4.93 |
| Dividend Yield | 1.95% |
| Shares Outstanding | 1.74B |
| Average Volume (1 week) | 6.51M |
| Average Volume (1 Month) | 6.08M |
| 52 Week Change | -3.1% |
| 52 Week High | 115.83 |
| 52 Week Low | 89.674 |
| Spread (Intraday) | 1.42 (1.34%) |
| Company Name | Abbott Laboratories |
| Address |
208 so lasalle st chicago, illinois 60604-1101 |
| Website | https://www.abbott.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
